Israeli biotech Gamida has successfully transplanted just its manipulated NiCord stem cells into patients with blood cancer. The impact is to reduce recovery times even further from the two years achieved from using NiCord combined with non-manipulated stem cells.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000878214&fid=1725
http://www.gamida-cell.com/press_item.asp?ID=57